ArticleCardiology research2025

Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction.

Riku Tsudome et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.